281 related articles for article (PubMed ID: 30247609)
1. Genetic Link Between Gender Dysphoria and Sex Hormone Signaling.
Foreman M; Hare L; York K; Balakrishnan K; Sánchez FJ; Harte F; Erasmus J; Vilain E; Harley VR
J Clin Endocrinol Metab; 2019 Feb; 104(2):390-396. PubMed ID: 30247609
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of Gender Dysphoria: androgen and estrogen receptor interaction.
Fernández R; Guillamon A; Cortés-Cortés J; Gómez-Gil E; Jácome A; Esteva I; Almaraz M; Mora M; Aranda G; Pásaro E
Psychoneuroendocrinology; 2018 Dec; 98():161-167. PubMed ID: 30165284
[TBL] [Abstract][Full Text] [Related]
3. Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen.
Fernández R; Ramírez K; Gómez-Gil E; Cortés-Cortés J; Mora M; Aranda G; Zayas ED; Esteva I; Almaraz MC; Guillamon A; Pásaro E
J Sex Med; 2020 Sep; 17(9):1795-1806. PubMed ID: 32636163
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor repeat length polymorphism associated with male-to-female transsexualism.
Hare L; Bernard P; Sánchez FJ; Baird PN; Vilain E; Kennedy T; Harley VR
Biol Psychiatry; 2009 Jan; 65(1):93-6. PubMed ID: 18962445
[TBL] [Abstract][Full Text] [Related]
5. Association study of ERβ, AR, and CYP19A1 genes and MtF transsexualism.
Fernández R; Esteva I; Gómez-Gil E; Rumbo T; Almaraz MC; Roda E; Haro-Mora JJ; Guillamón A; Pásaro E
J Sex Med; 2014 Dec; 11(12):2986-94. PubMed ID: 25124466
[TBL] [Abstract][Full Text] [Related]
6. Letter to the Editor: "Genetic Link Between Gender Dysphoria and Sex Hormone Signaling".
White PC
J Clin Endocrinol Metab; 2019 Oct; 104(10):4418-4419. PubMed ID: 30942857
[No Abstract] [Full Text] [Related]
7. Response to Letter to the Editor: "Genetic Link Between Gender Dysphoria and Sex Hormone Signaling".
Foreman M; Vilain E; Harley V
J Clin Endocrinol Metab; 2019 Oct; 104(10):4420. PubMed ID: 30942840
[No Abstract] [Full Text] [Related]
8. Gender Dysphoria and DNA.
Juli G; Juli MR; Juli R; Juli L
Psychiatr Danub; 2023 Oct; 35(Suppl 2):179-181. PubMed ID: 37800223
[TBL] [Abstract][Full Text] [Related]
9. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
Glintborg D; T'Sjoen G; Ravn P; Andersen MS
Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
[TBL] [Abstract][Full Text] [Related]
10. The influence of sex steroid treatment on insular connectivity in gender dysphoria.
Reed MB; Handschuh PA; Klöbl M; Konadu ME; Kaufmann U; Hahn A; Kranz GS; Spies M; Lanzenberger R
Psychoneuroendocrinology; 2023 Sep; 155():106336. PubMed ID: 37499299
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of brain-derived neurotrophic factor in patients diagnosed with gender dysphoria undergoing sex reassignment surgery.
Schneider MA; Andreazza T; Fontanari AM; Costa AB; Silva DC; Aguiar BW; Massuda R; Pedrini M; Gama CS; Schwarz K; Kauer-Sant'Anna M; Lobato MI
Trends Psychiatry Psychother; 2017; 39(1):43-47. PubMed ID: 28403322
[TBL] [Abstract][Full Text] [Related]
12. People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge.
Mepham N; Bouman WP; Arcelus J; Hayter M; Wylie KR
J Sex Med; 2014 Dec; 11(12):2995-3001. PubMed ID: 25213018
[TBL] [Abstract][Full Text] [Related]
13. Andrology of male-to-female transsexuals: influence of cross-sex hormone therapy on testicular function.
Schneider F; Kliesch S; Schlatt S; Neuhaus N
Andrology; 2017 Sep; 5(5):873-880. PubMed ID: 28914501
[TBL] [Abstract][Full Text] [Related]
14. Hormonal Gender Reassignment Treatment for Gender Dysphoria.
Meyer G; Boczek U; Bojunga J
Dtsch Arztebl Int; 2020 Oct; 117(43):725-732. PubMed ID: 33559593
[TBL] [Abstract][Full Text] [Related]
15. Cross-sex hormone therapy for gender dysphoria.
Fabris B; Bernardi S; Trombetta C
J Endocrinol Invest; 2015 Mar; 38(3):269-82. PubMed ID: 25403429
[TBL] [Abstract][Full Text] [Related]
16. The Misuse of Gender Dysphoria: Toward Greater Conceptual Clarity in Transgender Health.
Ashley F
Perspect Psychol Sci; 2021 Nov; 16(6):1159-1164. PubMed ID: 31747342
[TBL] [Abstract][Full Text] [Related]
17. Hormone Therapy for Transgender Adults.
Radix A
Urol Clin North Am; 2019 Nov; 46(4):467-473. PubMed ID: 31582021
[TBL] [Abstract][Full Text] [Related]
18. The CYP17 MspA1 Polymorphism and the Gender Dysphoria.
Fernández R; Cortés-Cortés J; Esteva I; Gómez-Gil E; Almaraz MC; Lema E; Rumbo T; Haro-Mora JJ; Roda E; Guillamón A; Pásaro E
J Sex Med; 2015 Jun; 12(6):1329-33. PubMed ID: 25929975
[TBL] [Abstract][Full Text] [Related]
19. The Role of Facial Gender Confirmation Surgery in the Treatment of Gender Dysphoria.
Esmonde N; Najafian A; Penkin A; Berli JU
J Craniofac Surg; 2019 Jul; 30(5):1387-1392. PubMed ID: 31299728
[TBL] [Abstract][Full Text] [Related]
20. Testicular Functions and Clinical Characterization of Patients with Gender Dysphoria (GD) Undergoing Sex Reassignment Surgery (SRS).
Schneider F; Neuhaus N; Wistuba J; Zitzmann M; Heß J; Mahler D; van Ahlen H; Schlatt S; Kliesch S
J Sex Med; 2015 Nov; 12(11):2190-200. PubMed ID: 26559385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
